These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15508815)

  • 21. Lipid-lowering therapy and risk of coronary events.
    Blakely JA
    JAMA; 2003 Apr 23-30; 289(16):2070-1; author reply 2071-2. PubMed ID: 12709461
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid-lowering therapy and risk of coronary events.
    Taylor WC
    JAMA; 2003 Apr 23-30; 289(16):2070; author reply 2071-2. PubMed ID: 12709462
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J
    Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
    [No Abstract]   [Full Text] [Related]  

  • 26. [No documentation for overtreatment with statins].
    Jensen GB
    Ugeskr Laeger; 2011 Sep; 173(38):2363; author reply 2363. PubMed ID: 22034664
    [No Abstract]   [Full Text] [Related]  

  • 27. Further LDL Lowering Could Reduce Cardiovascular Risk.
    Mechcatie E; Rosenberg K
    Am J Nurs; 2018 Nov; 118(11):55-56. PubMed ID: 30358599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The statins: potent drugs to lower cholesterol.
    Harv Mens Health Watch; 1998 Dec; 3(5):3-4. PubMed ID: 9846138
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE).
    Steg PG; Verdier JC; Carré F; Darne B; Ducardonnet A; Jullien G; Farnier M; Giral P; Haïat R;
    Arch Cardiovasc Dis; 2008; 101(11-12):723-35. PubMed ID: 19059567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 33. From fungus to pharmaceuticals--the chemistry of statins.
    McPherson PA
    Mini Rev Med Chem; 2012 Oct; 12(12):1250-60. PubMed ID: 22512563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of statin nephroprotective actions].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2002; 59(7):519-22. PubMed ID: 12516241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it over for ezetimibe?
    Robinson JG; Davidson M
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614
    [No Abstract]   [Full Text] [Related]  

  • 36. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
    Gotto AM
    Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypercholesterolaemia and its management.
    Bhatnagar D; Soran H; Durrington PN
    BMJ; 2008 Aug; 337():a993. PubMed ID: 18719012
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissociating HDL cholesterol from cardiovascular risk.
    Hausenloy DJ; Opie L; Yellon DM
    Lancet; 2010 Jul; 376(9738):305-6. PubMed ID: 20655104
    [No Abstract]   [Full Text] [Related]  

  • 39. HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque.
    Morishita R; Tomita N; Ogihara T
    Curr Drug Targets; 2002 Oct; 3(5):379-85. PubMed ID: 12182229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.
    de Lorgeril M; Salen P; Abramson J; Dodin S; Hamazaki T; Kostucki W; Okuyama H; Pavy B; Rabaeus M
    Arch Intern Med; 2010 Jun; 170(12):1032-6. PubMed ID: 20585068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.